Search

Introduction CASP specifically assesses post-stroke cognitive impairments. Its items are visual and as such can be administered to patients with severe expressive aphasia. We have previously shown that the CASP was more suitable than the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in aphasic patients. Our objective was to compare the above scales in non-aphasic stroke patients, and assess to what extent the solely visual items of the CASP were problematic in cases of neurovisual impairments. Methods Fifty non-aphasic patients admitted to Physical Medicine and Rehabilitation (PM&R) units after a recent left- or right-hemisphere stroke were evaluated with the CASP, MMSE and MoCA. We compared these three scales in terms of feasibility, concordance, and influence of neurovisual impairments on the total score. Results Twenty-nine men and 21 women were included (mean age 63 ± 14). For three patients, the MoCa was impossible to administer. It took significantly less time to administer the CASP (10 ± 5 min) than the MoCA (11 ± 5 min, P = 0.02), yet it still took more time than MMSE administration (7 ± 3 min, P < 10 −6 ). Neurovisual impairments affected equally the total scores of the three tests. Concordance between these scores was poor and only the CASP could specifically assess unilateral spatial neglect. Conclusion The sole visual format of the CASP scale seems suitable for administration in post-stroke patients. [ABSTRACT FROM AUTHOR]

Introduction Post-stroke aphasia makes it difficult to assess cognitive deficiencies. We thus developed the CASP, which can be administered without using language. Our objective was to compare the feasibility of the CASP, the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) in aphasic stroke patients. Material and methods All aphasic patients consecutively admitted to seven French rehabilitation units during a 4-month period after a recent first left hemispheric stroke were assessed with CASP, MMSE and MoCA. We determined the proportion of patients in whom it was impossible to administer at least one item from these 3 scales, and compared their administration times. Results Forty-four patients were included (age 64 ± 15, 26 males). The CASP was impossible to administer in eight of them (18%), compared with 16 for the MMSE (36%, P = 0.05) and 13 for the MoCA (30%, P = 0.21, NS). It was possible to administer the CASP in all of the patients with expressive aphasia, whereas the MMSE and the MoCA could not be administered. Administration times were longer for the CASP (13 ± 4 min) than for the MMSE (8 ± 3 min, P < 10 −6 ) and the MoCA (11 ± 5 min, P = 0.23, NS). Conclusion The CASP is more feasible than the MMSE and the MoCA in aphasic stroke patients. [ABSTRACT FROM AUTHOR]